Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report

The direct-acting oral anticoagulants (DOACs) would be the standard treatment for the prevention of stroke and thromboembolism in nonvalvular atrial fibrillation patients. The adverse effects of greatest concern are bleeding especially major bleeding. We present a case of a patient with a history of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hoyoung, Hong, Bo Young, Kim, Joon Sung, Park, Jisoo, Jung, Ji Yoon, Lim, Seong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Neurorehabilitation 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879380/
https://www.ncbi.nlm.nih.gov/pubmed/36741223
http://dx.doi.org/10.12786/bn.2021.14.e26
_version_ 1784878674782191616
author Jeong, Hoyoung
Hong, Bo Young
Kim, Joon Sung
Park, Jisoo
Jung, Ji Yoon
Lim, Seong Hoon
author_facet Jeong, Hoyoung
Hong, Bo Young
Kim, Joon Sung
Park, Jisoo
Jung, Ji Yoon
Lim, Seong Hoon
author_sort Jeong, Hoyoung
collection PubMed
description The direct-acting oral anticoagulants (DOACs) would be the standard treatment for the prevention of stroke and thromboembolism in nonvalvular atrial fibrillation patients. The adverse effects of greatest concern are bleeding especially major bleeding. We present a case of a patient with a history of nonvalvular atrial fibrillation and pacemaker, who developed severe anemia after massive hemoptysis while taking DOAC; however, he has continued taking DOAC. Through this case, we have summarized the current management of major bleeding associated with anticoagulation and discuss the optimal regimen for restarting of anticoagulation therapy.
format Online
Article
Text
id pubmed-9879380
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society for Neurorehabilitation
record_format MEDLINE/PubMed
spelling pubmed-98793802023-02-02 Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report Jeong, Hoyoung Hong, Bo Young Kim, Joon Sung Park, Jisoo Jung, Ji Yoon Lim, Seong Hoon Brain Neurorehabil Case Report The direct-acting oral anticoagulants (DOACs) would be the standard treatment for the prevention of stroke and thromboembolism in nonvalvular atrial fibrillation patients. The adverse effects of greatest concern are bleeding especially major bleeding. We present a case of a patient with a history of nonvalvular atrial fibrillation and pacemaker, who developed severe anemia after massive hemoptysis while taking DOAC; however, he has continued taking DOAC. Through this case, we have summarized the current management of major bleeding associated with anticoagulation and discuss the optimal regimen for restarting of anticoagulation therapy. Korean Society for Neurorehabilitation 2021-07-12 /pmc/articles/PMC9879380/ /pubmed/36741223 http://dx.doi.org/10.12786/bn.2021.14.e26 Text en Copyright © 2021. Korean Society for Neurorehabilitation https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jeong, Hoyoung
Hong, Bo Young
Kim, Joon Sung
Park, Jisoo
Jung, Ji Yoon
Lim, Seong Hoon
Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
title Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
title_full Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
title_fullStr Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
title_full_unstemmed Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
title_short Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
title_sort hemoptysis in quadriplegia with atrial fibrillation who was taking edoxaban: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879380/
https://www.ncbi.nlm.nih.gov/pubmed/36741223
http://dx.doi.org/10.12786/bn.2021.14.e26
work_keys_str_mv AT jeonghoyoung hemoptysisinquadriplegiawithatrialfibrillationwhowastakingedoxabanacasereport
AT hongboyoung hemoptysisinquadriplegiawithatrialfibrillationwhowastakingedoxabanacasereport
AT kimjoonsung hemoptysisinquadriplegiawithatrialfibrillationwhowastakingedoxabanacasereport
AT parkjisoo hemoptysisinquadriplegiawithatrialfibrillationwhowastakingedoxabanacasereport
AT jungjiyoon hemoptysisinquadriplegiawithatrialfibrillationwhowastakingedoxabanacasereport
AT limseonghoon hemoptysisinquadriplegiawithatrialfibrillationwhowastakingedoxabanacasereport

Ejemplares similares